Search Results - Matthew J. Schellenberg
- Showing 1 - 8 results of 8
-
1
ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes by Heeyoun Bunch, Deukyeong Kim, Masahiro Naganuma, Reiko Nakagawa, Anh Cong, Jaehyeon Jeong, Haruhiko Ehara, Hongha Vu, Jeong Ho Chang, Matthew J. Schellenberg, Shun-ichi Sekine
Published in Nature Communications (2023-12-01)Get full text
Article -
2
Dimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexes by Sowmiya Palani, Yuka Machida, Julia R. Alvey, Vandana Mishra, Allison L. Welter, Gaofeng Cui, Benoît Bragantini , Maria Victoria Botuyan, Anh T. Q. Cong, Georges Mer, Matthew J. Schellenberg, Yuichi J. Machida
Published in Nature Communications (2024-03-01)Get full text
Article -
3
BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ by Heeyoun Bunch, Jaehyeon Jeong, Keunsoo Kang, Doo Sin Jo, Anh T. Q. Cong, Deukyeong Kim, Donguk Kim, Dong-Hyung Cho, You Mie Lee, Benjamin P. C. Chen, Matthew J. Schellenberg, Stuart K. Calderwood
Published in Open Biology (2021-10-01)Get full text
Article -
4
Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia by Gordon J. Ruan, Xiaosheng Wu, Kimberly A. Gwin, Michelle K Manske, Jithma P. Abeykoon, Vaishali Bhardwaj, Taylor L. Witter, Matthew J. Schellenberg, Kari G Rabe, Neil E. Kay, Sameer A. Parikh, Thomas E. Witzig
Published in Haematologica (2024-04-01)Get full text
Article -
5
Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19 by Xiaosheng Wu, Michelle K. Manske, Gordon J. Ruan, Taylor L. Witter, Kevin E. Nowakowski, Jithma P. Abeykoon, Xinyi Tang, Yue Yu, Kimberly A. Gwin, Annie Wu, Vanessa Taupin, Vaishali Bhardwaj, Jonas Paludo, Surendra Dasari, Haidong Dong, Stephen M. Ansell, Andrew D. Badley, Matthew J. Schellenberg, Thomas E. Witzig
Published in iScience (2023-06-01)Get full text
Article -
6
Topobexin Targets a Unique Druggable Pocket of Topoisomerase II for Beta Isoform- Selective Control of DNA Damage During Anthracycline Chemotherapy by Jan Kubes, Galina Karabanovich, Anh T. Q. Cong, Iuliia Melnikova, Olga Lencova, Petra Kollarova, Hana Bavlovic Piskackova, Veronika Kerestes, Lenka Applova, Lise C. M. Arrouye, Julia R. Alvey, Jasmina Paluncic, Taylor L. Witter, Anna Jirkovska, Jiri Kunes, Petra Sterbova-Kovarikova, Caroline A. Austin, Martin Sterba, Tomas Simunek, Jaroslav Roh, Matthew J. Schellenberg
Published in Structural Dynamics (2025-10-01)Get full text
Article -
7
Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection by Jan Kubeš, Galina Karabanovich, Anh T. Q. Cong, Iuliia Melnikova, Olga Lenčová, Petra Kollárová, Hana Bavlovič Piskáčková, Veronika Keresteš, Lenka Applová, Lise C. M. Arrouye, Julia R. Alvey, Jasmina Paluncic, Taylor L. Witter, Anna Jirkovská, Jiří Kuneš, Petra Štěrbová-Kovaříková, Caroline A. Austin, Martin Štěrba, Tomáš Šimůnek, Jaroslav Roh, Matthew J. Schellenberg
Published in Nature Communications (2025-05-01)Get full text
Article -
8
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer by Swaathi Jayaraman, Xinyan Wu, Krishna R. Kalari, Xiaojia Tang, Mary J. Kuffel, Elizabeth S. Bruinsma, Shahrzad Jalali, Kevin L. Peterson, Cristina Correia, Rachel A. Kudgus, Scott H. Kaufmann, Santosh Renuse, James N. Ingle, Joel M. Reid, Matthew M. Ames, Alan P. Fields, Matthew J. Schellenberg, John R. Hawse, Akhilesh Pandey, Matthew P. Goetz
Published in npj Breast Cancer (2023-12-01)Get full text
Article
